Immunotherapy Of Neuroblastoma With Natural Killer T Cells Engineered To Target O-acetyl-GD2 |
Baylor College of Medicine / Andras Heczey, MD |
Young Investigator Grants |
2014 |
Texas |
Validation of microRNAs as valid targets in a pediatric sarcoma |
University of Texas Southwestern Medical Center / Mark Hatley |
Young Investigator Grants |
2011 |
Texas |
Targeting MYCN-amplified Neuroblastoma Through RORalpha Activation |
Baylor College of Medicine / Eveline Barbiere, MD |
Innovation Grants |
2016 |
Texas |
Modeling and Therapeutic Targeting of p21-Activated Kinase Members in High-Risk Rhabdomyosarcoma |
Baylor College of Medicine / Jason Yustein, MD/PhD |
Innovation Grants |
2018 |
Texas |
Fatigue and Carnitine Levels over Eight Cycles of Chemotherapy in Children and Adolescents.
|
Baylor College of Medicine / Marilyn Hockenberry |
Nurse Researcher Grants |
2008 |
Texas |
Pre-Clinical Testing of T cells Coded with CARs for DIPG |
University of Texas / Laurence Cooper, MD, PhD |
Innovation Grants |
2013 |
Texas |
Energy Balance Strategies for Decreasing Chemotherapy-Induced Cardiotoxicity |
University of Texas M.D. Anderson Cancer Center / Eugenie Kleinerman, MD |
Innovation Grants |
2018 |
Texas |
Immunotherapy for Pediatric Atypical Teratoid/Rhabdoid Tumor |
Baylor College of Medicine / William Decker, PhD |
Reach Grants |
2013 |
Texas |
B-lapachone as a Novel Targeted Therapy for ATRTs and other Pediatric Cancers
|
University of Texas Southwestern Medical Center / James Amatruda, MD, PhD |
Reach Grants |
2013 |
Texas |
Enhancing the Viability, Function, and Safety, of Genetically-Enhanced NK Cells Within the Solid Tumor Microenvironment With IL-15 and a Suicide Gene |
Baylor College of Medicine / Robin Parihar, MD, PhD |
Young Investigator Grants |
2015 |
Texas |